Načítá se...
Natalizumab (Tysabri)
Natalizumab is a humanized IgG4κ monoclonal antibody that is a selective adhesion molecule inhibitor, which prevents adhesion of leukocytes to endothelial cells. It is the first monoclonal antibody approved by the FDA for the treatment of relapsing-remitting MS. This article will review the mechanis...
Uloženo v:
| Vydáno v: | AJNR Am J Neuroradiol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Neuroradiology
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964985/ https://ncbi.nlm.nih.gov/pubmed/20688889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2226 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|